Volume | 1,100 |
|
|||||
News | - | ||||||
Day High | 4.96 | Low High |
|||||
Day Low | 4.82 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
XBiotech Inc | 4XB | Tradegate | Ordinary Share |
Price Change | Price Change % | Share Price | Last Trade | |
---|---|---|---|---|
-0.04 | -0.81% | 4.88 | 07:50:02 |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
4.96 | 4.82 | 4.96 | 4.88 | 4.92 |
Trades | Shares Traded | Average Volume | 52 Week Range |
---|---|---|---|
3 | 1,100 | - | 3.32 - 9.05 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
05:55:22 | 100 | 4.94 € | EUR |
XBiotech News
Date | Time | Source | News Article |
---|---|---|---|
20/6/2024 | 05:31 | GlobeNewswire Inc. | Ergebnisse aus randomisierter, doppelt verblindeter.. |
19/6/2024 | 01:35 | GlobeNewswire Inc. | XBiotech Results from Randomized Double-Blinded Phase 1/2.. |
05/1/2024 | 10:09 | GlobeNewswire Inc. | XBiotech beginnt mit dem Bau der neuen F&E-Anlage auf seinem.. |
05/1/2024 | 01:00 | GlobeNewswire Inc. | XBiotech to Begin Constructing New R&D Facility on its.. |
15/11/2023 | 14:32 | GlobeNewswire Inc. | Le Dr Alan Kivitz prend la tête du programme Natrunix,.. |
15/11/2023 | 01:00 | GlobeNewswire Inc. | Dr. Alan Kivitz to Chair XBiotech’s Natrunix Program in.. |
27/9/2023 | 15:00 | GlobeNewswire Inc. | XBiotech annonce l'achèvement du recrutement dans son essai.. |
26/9/2023 | 23:00 | GlobeNewswire Inc. | XBiotech Announces Enrollment Completion of Phase I Clinical.. |
Historical 4XB Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 6.20 | 6.20 | 4.82 | 5.54 | 638 | -1.32 | -21.29% |
1 Month | 7.55 | 7.55 | 4.82 | 6.43 | 1,216 | -2.67 | -35.36% |
3 Months | 7.40 | 9.05 | 4.82 | 7.12 | 722 | -2.52 | -34.05% |
6 Months | 3.70 | 9.05 | 3.52 | 5.72 | 709 | 1.18 | 31.89% |
1 Year | 4.62 | 9.05 | 3.32 | 5.36 | 644 | 0.26 | 5.63% |
3 Years | 4.62 | 9.05 | 3.32 | 5.36 | 644 | 0.26 | 5.63% |
5 Years | 4.62 | 9.05 | 3.32 | 5.36 | 644 | 0.26 | 5.63% |